Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q57028868 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241020233030.0 | ||
| 008 | 241020nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q57028868 | ||
| 024 | ‡a 0000-0001-5179-9674 ‡2 orcid | ||
| 024 | ‡a 0000-0002-3916-6046 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q57028868 | ||
| 100 | 0 | ‡a José Rosas ‡c researcher (ORCID 0000-0001-5179-9674) ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a José Rosas ‡c wetenschapper ‡9 nl | |
| 400 | 0 | ‡a José Rosas ‡c investigador ‡9 es | |
| 670 | ‡a Author's Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis | ||
| 670 | ‡a Author's ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts | ||
| 670 | ‡a Author's Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome | ||
| 670 | ‡a Author's Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review. | ||
| 670 | ‡a Author's Whipple's disease diagnosed during anti-tumor necrosis factor Alpha treatment: two case reports and review of the literature | ||
| 909 | ‡a (orcid) 0000000151799674 ‡9 1 | ||
| 909 | ‡a (orcid) 0000000239166046 ‡9 1 | ||
| 919 | ‡a clinicalrelevanceofmonitoringserumadalimumablevelsinaxialspondyloarthritis ‡A Clinical relevance of monitoring serum adalimumab levels in axial spondyloarthritis ‡9 1 | ||
| 919 | ‡a whipplesdiseasediagnosedduringantitumornecrosisfactor Alpha treatment2casereportsandreviewoftheliterature ‡A Whipple's disease diagnosed during anti-tumor necrosis factor Alpha treatment: two case reports and review of the literature ‡9 1 | ||
| 919 | ‡a serumdruglevelsofbiologicagentsinthemanagementofrheumatoidarthritisandspondyloarthritisasystematicreview ‡A Serum drug levels of biologic agents in the management of rheumatoid arthritis and spondyloarthritis: a systematic review. ‡9 1 | ||
| 919 | ‡a prevalenceandfactorsassociatedwithosteoporosisandfragilityfracturesinpatientswithprimarysjogrensyndrome ‡A Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome ‡9 1 | ||
| 919 | ‡a essdaiactivityindexofthesjogrensercohortanalysisandcomparisonwithothereuropeancohorts ‡A ESSDAI activity index of the SJÖGRENSER cohort: analysis and comparison with other European cohorts ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 LC|no 95004814 | ||
| 996 | ‡2 BNCHL|10000000000000000822636 | ||
| 996 | ‡2 BNE|XX5381728 | ||
| 996 | ‡2 LC|n 88076797 | ||
| 996 | ‡2 LC|ns2015003173 | ||
| 996 | ‡2 LC|no2013115327 | ||
| 996 | ‡2 LC|n 88285752 | ||
| 996 | ‡2 LC|n 2006036839 | ||
| 996 | ‡2 ARBABN|000057535 | ||
| 996 | ‡2 ISNI|0000000034545181 | ||
| 996 | ‡2 LC|ns2012004347 | ||
| 996 | ‡2 ISNI|0000000081255785 | ||
| 996 | ‡2 ISNI|0000000040422655 | ||
| 996 | ‡2 LC|ns2019002298 | ||
| 996 | ‡2 BNE|XX1769530 | ||
| 996 | ‡2 DNB|1057614483 | ||
| 996 | ‡2 LC|no2010096073 | ||
| 996 | ‡2 LC|n 87805316 | ||
| 996 | ‡2 SZ|1234615029 | ||
| 996 | ‡2 BNCHL|10000000000000000118725 | ||
| 996 | ‡2 SUDOC|244420394 | ||
| 996 | ‡2 SUDOC|254214770 | ||
| 996 | ‡2 DNB|133475247 | ||
| 996 | ‡2 ISNI|0000000119321478 | ||
| 996 | ‡2 NLA|000035684429 | ||
| 996 | ‡2 PTBNP|134884 | ||
| 996 | ‡2 BNCHL|10000000000000000078554 | ||
| 996 | ‡2 ISNI|0000000121334956 | ||
| 996 | ‡2 ISNI|000000002914878X | ||
| 996 | ‡2 ISNI|0000000032555490 | ||
| 996 | ‡2 BNC|981058612948506706 | ||
| 996 | ‡2 BNC|981059745615006706 | ||
| 996 | ‡2 ARBABN|000064182 | ||
| 996 | ‡2 ARBABN|000064183 | ||
| 996 | ‡2 ISNI|0000000068979279 | ||
| 996 | ‡2 ISNI|0000000047247845 | ||
| 996 | ‡2 LC|n 99049125 | ||
| 996 | ‡2 LC|no2007054573 | ||
| 996 | ‡2 LC|no 98098280 | ||
| 996 | ‡2 BNC|981058609796306706 | ||
| 996 | ‡2 PTBNP|1013691 | ||
| 996 | ‡2 NTA|133612899 | ||
| 996 | ‡2 PTBNP|225561 | ||
| 996 | ‡2 LC|ns2012004796 | ||
| 996 | ‡2 DNB|1234615029 | ||
| 996 | ‡2 SUDOC|170548155 | ||
| 996 | ‡2 ISNI|0000000048606117 | ||
| 996 | ‡2 ISNI|0000000069199004 | ||
| 996 | ‡2 DNB|1057443719 | ||
| 996 | ‡2 BLBNB|001131074 | ||
| 996 | ‡2 JPG|500065595 | ||
| 996 | ‡2 PLWABN|9811279566205606 | ||
| 996 | ‡2 NUKAT|n 2018284924 | ||
| 996 | ‡2 ISNI|0000000040888623 | ||
| 996 | ‡2 LC|no 98114348 | ||
| 996 | ‡2 BNCHL|10000000000000000048938 | ||
| 996 | ‡2 LC|ns2021003278 | ||
| 996 | ‡2 DNB|1204577153 | ||
| 996 | ‡2 LC|n 2023058973 | ||
| 996 | ‡2 LC|ns2021001375 | ||
| 996 | ‡2 LC|no2006053460 | ||
| 996 | ‡2 NUKAT|n 2016012481 | ||
| 996 | ‡2 SUDOC|267136692 | ||
| 996 | ‡2 SUDOC|186109474 | ||
| 996 | ‡2 BNCHL|10000000000000000821567 | ||
| 996 | ‡2 ISNI|0000000046782256 | ||
| 996 | ‡2 DNB|1157154085 | ||
| 996 | ‡2 BNF|16513046 | ||
| 996 | ‡2 ISNI|0000000044892865 | ||
| 996 | ‡2 SUDOC|120797577 | ||
| 996 | ‡2 SUDOC|153536632 | ||
| 996 | ‡2 LC|ns2018001245 | ||
| 996 | ‡2 LC|n 50082051 | ||
| 996 | ‡2 LC|n 98104642 | ||
| 996 | ‡2 LC|no2006089932 | ||
| 996 | ‡2 PTBNP|1764024 | ||
| 996 | ‡2 ISNI|0000000069412100 | ||
| 996 | ‡2 ISNI|0000000067551158 | ||
| 996 | ‡2 LC|no2007055419 | ||
| 996 | ‡2 LIH|LNB:_o_VB;=B_d_ | ||
| 996 | ‡2 BNE|XX5414529 | ||
| 996 | ‡2 ISNI|0000000080719816 | ||
| 996 | ‡2 LC|n 85159295 | ||
| 996 | ‡2 ISNI|0000000046126312 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
